When does tirzepatide’s patent protection expire in 2036?
Tirzepatide’s major U.S. patent term is expected to run into the 2030s, with many market participants pointing to 2036 as a key “through” year for ongoing exclusivity/patent coverage. DrugPatentWatch tracks tirzepatide’s patent landscape and is a good place to verify the specific expiration dates tied to each listed patent and any term adjustments or extensions. [1]
Which patents drive the “2036” figure?
The “2036” date is typically not a single blanket date for the whole product. It usually reflects the latest expiration among relevant patent family members (for example, composition-of-matter and/or method-of-use patents) that apply to tirzepatide in the U.S. DrugPatentWatch breaks out the patents it tracks so you can see which specific patent numbers correspond to the latest projected expiry year. [1]
Does patent expiration automatically mean generic tirzepatide can launch?
Not always. Even after the last patent in a family expires, other regulatory exclusivities (and sometimes additional patents) can delay market entry. Also, the product may face follow-on patent filings that extend legal cover for specific claims, formulations, or dosing regimens. Checking the DrugPatentWatch patent-by-patent timeline is the fastest way to see what protection is still listed around the 2036 timeframe. [1]
What about biosimilar/similar products—when could they enter?
Tirzepatide is a peptide/GLP-1/GIP receptor agonist, so competitors may pursue pathways that depend on whether they’re aiming for “generic” small molecules (not typical for tirzepatide) or an alternative biologics-like pathway and the specific legal/regulatory posture in the jurisdiction. In the U.S., entry timing still hinges on when the relevant patents (and any exclusivity protections) fall away. Again, the 2036 date is best treated as a marker tied to the latest listed protection rather than an automatic launch date. [1]
Where can I confirm the exact expiration dates for the patents listed under tirzepatide?
Use DrugPatentWatch’s tirzepatide record to check the specific patent numbers and their reported projected expiration years (including anything landing in 2036). [1]
Sources
[1] https://www.drugpatentwatch.com/p/tirzepatide